145 related articles for article (PubMed ID: 20218956)
21. Optimization and application of the group I ribozyme trans-splicing reaction.
Einvik C; Fiskaa T; Lundblad EW; Johansen S
Methods Mol Biol; 2004; 252():359-71. PubMed ID: 15017063
[TBL] [Abstract][Full Text] [Related]
22. In vivo evolution of a catalytic RNA couples trans-splicing to translation.
Olson KE; Dolan GF; Müller UF
PLoS One; 2014; 9(1):e86473. PubMed ID: 24466112
[TBL] [Abstract][Full Text] [Related]
23. Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns.
Carter JR; Keith JH; Barde PV; Fraser TS; Fraser MJ
BMC Mol Biol; 2010 Nov; 11():84. PubMed ID: 21078188
[TBL] [Abstract][Full Text] [Related]
24. Computational prediction of efficient splice sites for trans-splicing ribozymes.
Meluzzi D; Olson KE; Dolan GF; Arya G; Müller UF
RNA; 2012 Mar; 18(3):590-602. PubMed ID: 22274956
[TBL] [Abstract][Full Text] [Related]
25. A modified group I intron can function as both a ribozyme and a 5' exon in a trans-exon ligation reaction.
Tasiouka KI; Burke JM
Gene; 1994 Jun; 144(1):1-7. PubMed ID: 8026742
[TBL] [Abstract][Full Text] [Related]
26. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
[TBL] [Abstract][Full Text] [Related]
27. Delta ribozyme has the ability to cleave in transan mRNA.
Roy G; Ananvoranich S; Perreault JP
Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
[TBL] [Abstract][Full Text] [Related]
28. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
[TBL] [Abstract][Full Text] [Related]
29. Design of highly specific cytotoxins by using trans-splicing ribozymes.
Ayre BG; Köhler U; Goodman HM; Haseloff J
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3507-12. PubMed ID: 10097066
[TBL] [Abstract][Full Text] [Related]
30. Drugs made of RNA: development and application of engineered RNAs for gene therapy.
Drude I; Dombos V; Vauléon S; Müller S
Mini Rev Med Chem; 2007 Sep; 7(9):912-31. PubMed ID: 17897081
[TBL] [Abstract][Full Text] [Related]
31. Group I intron ribozymes.
Nielsen H
Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064
[TBL] [Abstract][Full Text] [Related]
32. In vivo excision of a single targeted nucleotide from an mRNA by a trans excision-splicing ribozyme.
Baum DA; Testa SM
RNA; 2005 Jun; 11(6):897-905. PubMed ID: 15872183
[TBL] [Abstract][Full Text] [Related]
33. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA.
Lan N; Rooney BL; Lee SW; Howrey RP; Smith CA; Sullenger BA
Mol Ther; 2000 Sep; 2(3):245-55. PubMed ID: 10985955
[TBL] [Abstract][Full Text] [Related]
34. Group II intron ribozymes that cleave DNA and RNA linkages with similar efficiency, and lack contacts with substrate 2'-hydroxyl groups.
Griffin EA; Qin Z; Michels WJ; Pyle AM
Chem Biol; 1995 Nov; 2(11):761-70. PubMed ID: 9383483
[TBL] [Abstract][Full Text] [Related]
35. Modulating the splicing activity of Tetrahymena ribozyme via RNA self-assembly.
Hasegawa S; Rao J
FEBS Lett; 2006 Mar; 580(6):1592-6. PubMed ID: 16472807
[TBL] [Abstract][Full Text] [Related]
36. Ribozymes as therapeutic tools for genetic disease.
Phylactou LA; Kilpatrick MW; Wood MJ
Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
[TBL] [Abstract][Full Text] [Related]
37. Catalysis of RNA cleavage by a ribozyme derived from the group I intron of Anabaena pre-tRNA(Leu).
Zaug AJ; Dávila-Aponte JA; Cech TR
Biochemistry; 1994 Dec; 33(49):14935-47. PubMed ID: 7527660
[TBL] [Abstract][Full Text] [Related]
38. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
39. Functional repair of a mutant chloride channel using a trans-splicing ribozyme.
Rogers CS; Vanoye CG; Sullenger BA; George AL
J Clin Invest; 2002 Dec; 110(12):1783-9. PubMed ID: 12488428
[TBL] [Abstract][Full Text] [Related]
40. Group I-like ribozymes with a novel core organization perform obligate sequential hydrolytic cleavages at two processing sites.
Einvik C; Nielsen H; Westhof E; Michel F; Johansen S
RNA; 1998 May; 4(5):530-41. PubMed ID: 9582095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
